How is digital pathology used in clinical trials? Because digital pathology as a discipline began with the aim of streamlining clinical trials, one could assume that this is currently the default.
Unfortunately, this is not the case… In today's discussion, our guest, Dr. Monika Lamba, a pathologist from Q2 Solutions, the lab division of IQVIA, sheds light on how digital pathology revolutionizes the landscape of clinical trials but also where we can still see the gaps.
In this engaging conversation, we discover how the origins of telepathology marked the inception of digital pathology and its journey to becoming an essential component of clinical trials.
Dr. Lamba walks us through the complexities of clinical trials, their organization, and patient matching across multiple sites and international boundaries.
As we unravel the role of pathology in clinical trials, we delve into how eligibility criteria, participant engagement, and informed consent are intricately woven into the process. Dr. Lamba educates us on the critical role of pathology in stratifying and randomizing patients, as well as evaluating outcome measures.
From disease staging to pathologic complete response assessments, pathology guides the way toward precision medicine and targeted therapies. Don't miss this captivating episode where we explore the synergy between digital pathology and clinical trials, paving the path for medical advancements and transformative healthcare solutions. Tune in now to expand your horizons on the ever-evolving intersection of digital pathology and clinical trials.
Start your 7-day free trial: Digital Pathology Club Membership
EPISODES YOU WILL ALSO ENJOY:
DIGITAL PATHOLOGY RESOURCES:
Become a Digital Pathology Trailblazer and See you inside the club: Digital Pathology Club Membership
How is digital pathology used in clinical trials? Because digital pathology as a discipline began with the aim of streamlining clinical trials, one could assume that this is currently the default.
Unfortunately, this is not the case… In today's discussion, our guest, Dr. Monika Lamba, a pathologist from Q2 Solutions, the lab division of IQVIA, sheds light on how digital pathology revolutionizes the landscape of clinical trials but also where we can still see the gaps.
In this engaging conversation, we discover how the origins of telepathology marked the inception of digital pathology and its journey to becoming an essential component of clinical trials.
Dr. Lamba walks us through the complexities of clinical trials, their organization, and patient matching across multiple sites and international boundaries.
As we unravel the role of pathology in clinical trials, we delve into how eligibility criteria, participant engagement, and informed consent are intricately woven into the process. Dr. Lamba educates us on the critical role of pathology in stratifying and randomizing patients, as well as evaluating outcome measures.
From disease staging to pathologic complete response assessments, pathology guides the way toward precision medicine and targeted therapies. Don't miss this captivating episode where we explore the synergy between digital pathology and clinical trials, paving the path for medical advancements and transformative healthcare solutions. Tune in now to expand your horizons on the ever-evolving intersection of digital pathology and clinical trials.
Start your 7-day free trial: Digital Pathology Club Membership
EPISODES YOU WILL ALSO ENJOY:
DIGITAL PATHOLOGY RESOURCES:
Become a Digital Pathology Trailblazer and See you inside the club: Digital Pathology Club Membership